SF3B1 Splicing Mutation in the Context of Therapy Related MDS

被引：0
|
作者：
Volpe, Virginia Olivia
Al Ali, Najla
Chan, Onyee
Padron, Eric
Sallman, David A.
Komrokji, Rami S.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138833
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The splicing factor SF3B1 is involved in brown adipocyte thermogenic activation
    Castella, Moises
    Mestres-Arenas, Alberto
    Gavalda-Navarro, Aleix
    Blasco-Roset, Albert
    Quesada-Lopez, Tania
    Romero-Carraminana, Ines
    Giralt, Marta
    Villarroya, Francesc
    Cereijo, Ruben
    BIOCHEMICAL PHARMACOLOGY, 2024, 220
  • [32] IDENTIFICATION OF ALTERED AND CRYPTIC-SPLICING IN SF3B1 MUTANT MYELODYSPLASTIC SYNDROMES AND ISOGENIC MODELS OF SF3B1-K700E MUTATION
    Liberante, F.
    Lappin, K.
    Savage, K.
    Mills, K.
    HAEMATOLOGICA, 2016, 101 : 67 - 67
  • [33] THE SPLICEOSOMAL COMPONENT SF3B1 IS ESSENTIAL FOR HEMATOPOIETIC DIFFERENTIATION AND SPLICING FIDELITY
    Bowman, Teresa
    Cameron, Rosannah
    McKinstry, Mia
    De La Garza, Adriana
    Nik, Sara
    Payne, Sara
    Smith, Peter
    Buonamici, Silvia
    Bradley, Robert
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (09) : S51 - S51
  • [34] ABERRANT SPLICING DURING ERYTHROID DIFFERENTIATION IN SF3B1 MUTATED SIDEROBLASTIC
    Conte, S.
    Vesterlund, L.
    Katayama, S.
    Karimi, M.
    Unneberg, P.
    Papaemmanuil, E.
    Jansson, M.
    Mortera-Blanco, T.
    Dimitriou, M.
    Sander, B.
    Skoog, T.
    Campbells, P.
    Kere, J.
    Hellstrom-Lindberg, E.
    HAEMATOLOGICA, 2013, 98 : 73 - 74
  • [35] MicroRNA biogenesis is broadly disrupted by inhibition of the splicing factor SF3B1
    Velasco, Angela Downie Ruiz
    Parsons, Aimee L.
    Heatley, Matthew C.
    Martin, Athena R. G.
    Smart, Alfredo D.
    Shah, Niraj
    Jopling, Catherine L.
    NUCLEIC ACIDS RESEARCH, 2024, 52 (15) : 9210 - 9229
  • [36] Understanding the Role of Mutations in SF3B1 and Splicing in Chronic Lymphocytic Leukemia
    Wu, Catherine J.
    BLOOD, 2012, 120 (21)
  • [37] Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation
    Li, Zhuang
    Zhao, Bo
    Shi, Yueru
    Liang, Yuqi
    Qian, Rui
    Wan, Youzhong
    JOURNAL OF BIOCHEMISTRY, 2021, 170 (01): : 69 - 77
  • [38] Myeloid Neoplasms with Ring Sideroblasts without SF3B1 Mutation
    Bhaysar, S.
    Bailey, N. G.
    Liu, Y.
    Coyne, W. E.
    Aggarwal, N.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 925 - 926
  • [39] Therapeutic Applications of a Unique Calcium Channel Blocker to Target SF3B1 MDS
    Kongkiatkamon, Sunisa
    Tiwari, Anand
    Adema, Vera
    Kerr, Cassandra M.
    Przychodzen, Bartlomiej
    Awada, Hassan
    Durrani, Jibran
    Parker, Yvonne
    Adams, Drew
    Fedorov, Yuriy
    Carraway, Hetty E.
    Yang, Chao-Yie
    Sekeres, Mikkael A.
    Lindner, Daniel J.
    Phillips, James G.
    Maciejewski, Jaroslaw P.
    Visconte, Valeria
    BLOOD, 2019, 134
  • [40] Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
    Malcovati, Luca
    Papaemmanuil, Elli
    Hellstrom-Lindberg, Eva
    Boultwood, Jacqueline
    Bowen, David
    Vyas, Paresh
    Pascutto, Cristiana
    Della Porta, Matteo G.
    Pellagatti, Andrea
    Groves, Michael J.
    Godfrey, Anna L.
    Ambaglio, Ilaria
    Galli, Anna
    Travaglino, Erica
    Conte, Simona
    Tauro, Sudhir
    Keenan, Norene
    Hyslop, Ann
    Hinton, Jonathan
    Mudie, Laura J.
    Passerini, Carlo Gambacorti
    Cross, Nicholas C. P.
    Wainscoat, James S.
    Green, Anthony R.
    Futreal, P. Andrew
    Stratton, Michael R.
    Campbell, Peter J.
    Cazzola, Mario
    BLOOD, 2011, 118 (21) : 3 - 4
12345